{"id":215,"date":"2021-02-09T22:49:43","date_gmt":"2021-02-09T22:49:43","guid":{"rendered":"https:\/\/kpli.hu\/?p=215"},"modified":"2022-11-30T13:25:31","modified_gmt":"2022-11-30T13:25:31","slug":"decision-of-ogyei-regarding-pharmaceutical-commercial-practice","status":"publish","type":"post","link":"https:\/\/kpli.hu\/en\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\/","title":{"rendered":"Decision of OGY\u00c9I regarding pharmaceutical commercial practice"},"content":{"rendered":"<p>In February 2021 OGY\u00c9I published a new decision in which it imposed a penalty of HUF 34 million on a pharmaceutical company.<\/p>\n<p><strong>Infringements of the Company<\/strong><br \/>\nThe Company provided health care professionals with information materials containing inaccurate claims not proven by literature and being in contradiction with the statements made in the summary of product characteristics.<br \/>\nThe Company concluded contracts for lecturing of marketing materials related to its product, and for expert activities. It concluded contracts with health care professionals entitled to prescribe medicines, whose subject matter was to write an own case related to the Company\u2019s medicine in the Company\u2019s promotional brochure for the promotion of the acquisition, sales and consumption of the medicine.<br \/>\nBy avoiding physicians and the chief pharmacist employed by the in-patient health care service provider the Company handed over medicine samples and donated medicines directly to hospital departments and other organisational units.<br \/>\nIn the frames of contractual legal relationship, within the scope of its commercial practices, the Company provided prohibited financial advantages to health care professionals. It provided health care professionals with gifts that were not interrelated with the health care activity of persons entitled to prescribe and distribute medicines and therapeutic medical devices. The Company provided health care professionals entitled to prescribe medicinal products\/medical aids with hospitality that qualifies hospitality outside the frames of a professional-scientific event. In the case of a company event, it exceeded the limit of hospitality and provided health care professionals with hospitality in excess of that.<\/p>\n<p><strong>Reporting obligation<\/strong><br \/>\nThe Company failed to report professional events organised by it and failed to complete attendance list. It did not furnish OGY\u00c9I with deeds certifying its compliance with payment obligations after medical sales representatives.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In February 2021 OGY\u00c9I published a new decision in which it imposed a penalty of HUF 34 million on a pharmaceutical company. Infringements of the Company The Company provided health care professionals with information materials containing inaccurate claims not proven by literature and being in contradiction with the statements made in the summary of product [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":243,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-215","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Decision of OGY\u00c9I regarding pharmaceutical commercial practice - Kelemen Kinga \u00fcgyv\u00e9di iroda<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kpli.hu\/en\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Decision of OGY\u00c9I regarding pharmaceutical commercial practice - Kelemen Kinga \u00fcgyv\u00e9di iroda\" \/>\n<meta property=\"og:description\" content=\"In February 2021 OGY\u00c9I published a new decision in which it imposed a penalty of HUF 34 million on a pharmaceutical company. Infringements of the Company The Company provided health care professionals with information materials containing inaccurate claims not proven by literature and being in contradiction with the statements made in the summary of product [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kpli.hu\/en\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\/\" \/>\n<meta property=\"og:site_name\" content=\"Kelemen Kinga \u00fcgyv\u00e9di iroda\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-09T22:49:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-11-30T13:25:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kpli.hu\/wp-content\/uploads\/2021\/03\/pic1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"kpli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"kpli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/kpli.hu\\\/en\\\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kpli.hu\\\/en\\\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\\\/\"},\"author\":{\"name\":\"kpli\",\"@id\":\"https:\\\/\\\/kpli.hu\\\/#\\\/schema\\\/person\\\/6c2cd11954e251ca7ab7da15637cf079\"},\"headline\":\"Decision of OGY\u00c9I regarding pharmaceutical commercial practice\",\"datePublished\":\"2021-02-09T22:49:43+00:00\",\"dateModified\":\"2022-11-30T13:25:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/kpli.hu\\\/en\\\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\\\/\"},\"wordCount\":293,\"image\":{\"@id\":\"https:\\\/\\\/kpli.hu\\\/en\\\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kpli.hu\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/pic1.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kpli.hu\\\/en\\\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\\\/\",\"url\":\"https:\\\/\\\/kpli.hu\\\/en\\\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\\\/\",\"name\":\"Decision of OGY\u00c9I regarding pharmaceutical commercial practice - Kelemen Kinga \u00fcgyv\u00e9di iroda\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kpli.hu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/kpli.hu\\\/en\\\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/kpli.hu\\\/en\\\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kpli.hu\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/pic1.jpg\",\"datePublished\":\"2021-02-09T22:49:43+00:00\",\"dateModified\":\"2022-11-30T13:25:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/kpli.hu\\\/#\\\/schema\\\/person\\\/6c2cd11954e251ca7ab7da15637cf079\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kpli.hu\\\/en\\\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kpli.hu\\\/en\\\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/kpli.hu\\\/en\\\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\\\/#primaryimage\",\"url\":\"https:\\\/\\\/kpli.hu\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/pic1.jpg\",\"contentUrl\":\"https:\\\/\\\/kpli.hu\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/pic1.jpg\",\"width\":600,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kpli.hu\\\/en\\\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Kezd\u0151lap\",\"item\":\"https:\\\/\\\/kpli.hu\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Decision of OGY\u00c9I regarding pharmaceutical commercial practice\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kpli.hu\\\/#website\",\"url\":\"https:\\\/\\\/kpli.hu\\\/\",\"name\":\"Kelemen Kinga \u00fcgyv\u00e9di iroda\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kpli.hu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/kpli.hu\\\/#\\\/schema\\\/person\\\/6c2cd11954e251ca7ab7da15637cf079\",\"name\":\"kpli\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b8c03c5c95eb3534d67c38b82a5fcb1ef4fcc3ba752aa5ee9cd3c360a995253a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b8c03c5c95eb3534d67c38b82a5fcb1ef4fcc3ba752aa5ee9cd3c360a995253a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b8c03c5c95eb3534d67c38b82a5fcb1ef4fcc3ba752aa5ee9cd3c360a995253a?s=96&d=mm&r=g\",\"caption\":\"kpli\"},\"sameAs\":[\"https:\\\/\\\/kpli.hu\"],\"url\":\"https:\\\/\\\/kpli.hu\\\/en\\\/author\\\/kpli\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Decision of OGY\u00c9I regarding pharmaceutical commercial practice - Kelemen Kinga \u00fcgyv\u00e9di iroda","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kpli.hu\/en\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\/","og_locale":"en_US","og_type":"article","og_title":"Decision of OGY\u00c9I regarding pharmaceutical commercial practice - Kelemen Kinga \u00fcgyv\u00e9di iroda","og_description":"In February 2021 OGY\u00c9I published a new decision in which it imposed a penalty of HUF 34 million on a pharmaceutical company. Infringements of the Company The Company provided health care professionals with information materials containing inaccurate claims not proven by literature and being in contradiction with the statements made in the summary of product [&hellip;]","og_url":"https:\/\/kpli.hu\/en\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\/","og_site_name":"Kelemen Kinga \u00fcgyv\u00e9di iroda","article_published_time":"2021-02-09T22:49:43+00:00","article_modified_time":"2022-11-30T13:25:31+00:00","og_image":[{"width":600,"height":600,"url":"https:\/\/kpli.hu\/wp-content\/uploads\/2021\/03\/pic1.jpg","type":"image\/jpeg"}],"author":"kpli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"kpli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kpli.hu\/en\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\/#article","isPartOf":{"@id":"https:\/\/kpli.hu\/en\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\/"},"author":{"name":"kpli","@id":"https:\/\/kpli.hu\/#\/schema\/person\/6c2cd11954e251ca7ab7da15637cf079"},"headline":"Decision of OGY\u00c9I regarding pharmaceutical commercial practice","datePublished":"2021-02-09T22:49:43+00:00","dateModified":"2022-11-30T13:25:31+00:00","mainEntityOfPage":{"@id":"https:\/\/kpli.hu\/en\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\/"},"wordCount":293,"image":{"@id":"https:\/\/kpli.hu\/en\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\/#primaryimage"},"thumbnailUrl":"https:\/\/kpli.hu\/wp-content\/uploads\/2021\/03\/pic1.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/kpli.hu\/en\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\/","url":"https:\/\/kpli.hu\/en\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\/","name":"Decision of OGY\u00c9I regarding pharmaceutical commercial practice - Kelemen Kinga \u00fcgyv\u00e9di iroda","isPartOf":{"@id":"https:\/\/kpli.hu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kpli.hu\/en\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\/#primaryimage"},"image":{"@id":"https:\/\/kpli.hu\/en\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\/#primaryimage"},"thumbnailUrl":"https:\/\/kpli.hu\/wp-content\/uploads\/2021\/03\/pic1.jpg","datePublished":"2021-02-09T22:49:43+00:00","dateModified":"2022-11-30T13:25:31+00:00","author":{"@id":"https:\/\/kpli.hu\/#\/schema\/person\/6c2cd11954e251ca7ab7da15637cf079"},"breadcrumb":{"@id":"https:\/\/kpli.hu\/en\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kpli.hu\/en\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kpli.hu\/en\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\/#primaryimage","url":"https:\/\/kpli.hu\/wp-content\/uploads\/2021\/03\/pic1.jpg","contentUrl":"https:\/\/kpli.hu\/wp-content\/uploads\/2021\/03\/pic1.jpg","width":600,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/kpli.hu\/en\/decision-of-ogyei-regarding-pharmaceutical-commercial-practice\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Kezd\u0151lap","item":"https:\/\/kpli.hu\/en\/"},{"@type":"ListItem","position":2,"name":"Decision of OGY\u00c9I regarding pharmaceutical commercial practice"}]},{"@type":"WebSite","@id":"https:\/\/kpli.hu\/#website","url":"https:\/\/kpli.hu\/","name":"Kelemen Kinga \u00fcgyv\u00e9di iroda","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kpli.hu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/kpli.hu\/#\/schema\/person\/6c2cd11954e251ca7ab7da15637cf079","name":"kpli","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b8c03c5c95eb3534d67c38b82a5fcb1ef4fcc3ba752aa5ee9cd3c360a995253a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b8c03c5c95eb3534d67c38b82a5fcb1ef4fcc3ba752aa5ee9cd3c360a995253a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b8c03c5c95eb3534d67c38b82a5fcb1ef4fcc3ba752aa5ee9cd3c360a995253a?s=96&d=mm&r=g","caption":"kpli"},"sameAs":["https:\/\/kpli.hu"],"url":"https:\/\/kpli.hu\/en\/author\/kpli\/"}]}},"_links":{"self":[{"href":"https:\/\/kpli.hu\/en\/wp-json\/wp\/v2\/posts\/215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kpli.hu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kpli.hu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kpli.hu\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kpli.hu\/en\/wp-json\/wp\/v2\/comments?post=215"}],"version-history":[{"count":1,"href":"https:\/\/kpli.hu\/en\/wp-json\/wp\/v2\/posts\/215\/revisions"}],"predecessor-version":[{"id":216,"href":"https:\/\/kpli.hu\/en\/wp-json\/wp\/v2\/posts\/215\/revisions\/216"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kpli.hu\/en\/wp-json\/wp\/v2\/media\/243"}],"wp:attachment":[{"href":"https:\/\/kpli.hu\/en\/wp-json\/wp\/v2\/media?parent=215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kpli.hu\/en\/wp-json\/wp\/v2\/categories?post=215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kpli.hu\/en\/wp-json\/wp\/v2\/tags?post=215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}